Halfmann, Peter J.
Iwatsuki-Horimoto, Kiyoko http://orcid.org/0000-0002-8266-020X
Kuroda, Makoto
Hirata, Yuichiro
Yamayoshi, Seiya http://orcid.org/0000-0001-7768-5157
Iida, Shun http://orcid.org/0000-0003-2258-9031
Uraki, Ryuta http://orcid.org/0000-0003-0890-1922
Ito, Mutsumi
Ueki, Hiroshi http://orcid.org/0000-0002-6557-0771
Furusawa, Yuri
Sakai-Tagawa, Yuko
Kiso, Maki
Armbrust, Tammy
Spyra, Sam
Maeda, Ken http://orcid.org/0000-0002-3488-5439
Wang, Zhongde http://orcid.org/0000-0003-2441-4729
Imai, Masaki http://orcid.org/0000-0001-6988-1975
Suzuki, Tadaki http://orcid.org/0000-0002-3820-9542
Kawaoka, Yoshihiro http://orcid.org/0000-0001-5061-8296
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (75N93021C00014)
Japan Agency for Medical Research and Development (JP21fk0108552, JP21fk0108615, JP223fa627001)
Article History
Received: 30 April 2023
Accepted: 6 March 2024
First Online: 15 March 2024
Competing interests
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. S.G. has received unrelated funding support from Kyorin Pharmaceutical Co., Ltd. and is a founder and shareholder of HiLung Inc. The remaining authors declare that they have no competing interests.